InsiderSignal.AI

InsiderSignal.ai

LQDA - Liquidia Corp

Insider Sale by Kaseta Michael (CFO, COO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Kaseta Michael, serving as CFO, COO at Liquidia Corp (LQDA), sold 142,390 shares at $40.14 per share, for a total transaction value of $5,715,240.00. Following this transaction, Kaseta Michael now holds 353,356 shares of LQDA.

This sale represents a 29.00% decrease in Kaseta Michael's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 16, 2026, 2 days after the trade was made.

Liquidia Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Kaseta Michael

Kaseta Michael

CFO, COO

Michael Kaseta is the Chief Financial Officer and Chief Operating Officer of Liquidia Corp (NASDAQ: LQDA), a biopharmaceutical company[[1]](https://www.investing.com/news/insider-trading-news/liquidia-corp-cfo-michael-kaseta-sells-shares-worth-13503-93CH-3907238)[[2]](https://www.gurufocus.com/insider/179934/michael-kaseta). As of early 2025, Kaseta held approximately 401,755 shares of Liquidia Corp stock, demonstrating significant personal investment in the company[[2]](https://www.gurufocus.com/insider/179934/michael-kaseta). His insider trading activity reflects a disciplined approach to equity management, including the execution of a pre-arranged trading plan adopted in December 2023 to manage tax obligations related to restricted stock unit settlements[[1]](https://www.investing.com/news/insider-trading-news/liquidia-corp-cfo-michael-kaseta-sells-shares-worth-13503-93CH-3907238). Kaseta has demonstrated active engagement in corporate governance and equity markets, with SEC filings showing 11 transactions in Liquidia Corp over a five-year period[[2]](https://www.gurufocus.com/insider/179934/michael-kaseta). His shareholdings and regular market transactions position him as a key stakeholder in the company's strategic direction. Beyond his primary role at Liquidia, Kaseta has also served as a director at Alimera Sciences Inc., indicating broader experience in the pharmaceutical and life sciences sector[[2]](https://www.gurufocus.com/insider/179934/michael-kaseta).

View full insider profile →

Trade Price

$40.14

Quantity

142,390

Total Value

$5,715,240.00

Shares Owned

353,356

Trade Date

Tuesday, April 14, 2026

3 days ago

SEC Filing Date

Thursday, April 16, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Liquidia Corp

Company Overview

No company information available
View news mentioning LQDA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5698944

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime